Smoking cessation in England: intentionality, anticipated ease of quitting and advice provision

Social Science & Medicine
L TwiggPaul Iggulden

Abstract

Smoking prevalence in England continues to reduce but further reduction is increasingly difficult. Cessation policy has successfully targeted those who want to quit but further reduction will need to shift attention to more difficult 'core smoker' populations. Following the established 'stages of change' perspective, this paper considers the characteristics of people who do not intend to quit smoking, anticipate difficulties in quitting and have not received advice about quitting. We deploy multilevel models of data drawn from the Health Survey for England years 2002-2004, and the NHS Primary Care Trust Patient Surveys for 2004 and 2005. It was found that variations in intentionality and anticipated ease of quitting are associated with individual factors such as smoking intensity, parental smoking, age/length of time as a smoker and the nature of the advice-giving consultation. Household composition and household income are also implicated in the intention to quit and anticipated difficulties in quitting. Once individual and household factors are taken into account the only identifiable area-level variation is reduced intentionality towards quitting in rural areas. We conclude by arguing that further gains in smoking cessation ...Continue Reading

References

Sep 10, 1988·BMJ : British Medical Journal·N Wald
Mar 12, 1999·Preventive Medicine·A J FarkasJ P Pierce
Mar 13, 1999·Social Science & Medicine·C DuncanG Moon
Jul 27, 1999·Preventive Medicine·M OslerP Schnohr
Oct 6, 1999·Health Education Research·H Graham, G Der
Sep 19, 2001·Health & Social Care in the Community·M Powell, G Moon
Jun 8, 2002·Paediatric Respiratory Reviews·A Charlton
Nov 19, 2002·Social Science & Medicine·L McKieA S Lennox
May 17, 2003·BMJ : British Medical Journal·Martin J JarvisLesley Owen
May 31, 2003·BMJ : British Medical Journal·Robert Paul RiemsmaAnne Walker
Sep 6, 2003·Tobacco Control·L BauldUNKNOWN English Evaluation of Smoking Cessation Services (EESCS)
Feb 7, 2004·BMJ : British Medical Journal·Robert West
Apr 23, 2005·Addiction·Ann McNeillPatsy Bailey
Jun 1, 2005·European Journal of Public Health·A Jeanne M van LoonJohan Ormel
Jan 27, 2006·Tobacco Control·B PolandR Sparks
Apr 12, 2006·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Mark P DoescherL Gary Hart
Nov 30, 2006·Tobacco Control·Katrina GiskesJohan P Mackenbach
Apr 10, 2008·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Tresza D HutchesonGenevieve N Casey
Oct 3, 2008·Alcoholism, Clinical and Experimental Research·Emily L R HarrisonSherry A McKee

❮ Previous
Next ❯

Citations

Nov 26, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Marcus R MunafòGeorge Davey Smith
Mar 6, 2012·Sociology of Health & Illness·Katherine L FrohlichJoy Johnson
Oct 26, 2010·Social Science & Medicine·Miriam J StewartMadeline Boscoe
Jan 28, 2012·Health & Place·Kerstin Hermes, Michael Poulsen
Aug 29, 2009·Health Policy·Antony Roger DenmanPaul Scott Phillips
Dec 20, 2014·International Journal of Public Health·Edward GriffinRoss Barnet
Dec 24, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Rosemary HiscockVivien Daley
Jul 31, 2012·Perspectives in Public Health·Christopher J Groves-KirkbyMerryn Ekberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.